HFSA Board Certification Review 2021

• Heart Failure Epidemiology and Risk Factors
• Sadiya Khan

• Pathophysiology I: Cellular and Energetic Considerations
• Daniel Burkhoff

• Pathophysiology II: Hemodynamic, Structural, and Neurohormonal Considerations
• Daniel Burkhoff

• Diagnosis and Clinical Assessment
• Mark Drazner

• Cardio-Oncology for the HF boards
• Bonnie Ky

• Clinico-Pathologic Correlates in Heart Failure/ Images for the Heart Failure Boards
• Jon Lomasney

• Statistics for the HF Board
• Brian Claggett

• Cardiac Transplantation

• Advanced Heart Failure: Defining the Phenotype and Patient Selection for Advanced Therapies
• Nancy Sweitzer

• Immunology: The Basics, PRA, Sensitization, Crossmatch
• Sean Pinney

• Rejection: Cellular and Antibody Mediated
• Sean Pinney

• Managing Immunosuppression and Drugs
• Michelle Kittleson

• Heart Transplant, Clinical Outcomes and Complications
• Michelle Kittleson

• Q&A Panel I
• Akshay Desai, Nancy Sweitzer, Jonathan Rich, Maria Rosa

• Key Issues in HF Management

• Hemodynamics in HF I
• James Fang

• Hemodynamics in HF II
• James Fang

• Drug Therapy for Chronic HF I: Focus on established therapies (ACE/ARB/Beta-blocker/MRA/Digoxin/Hydralazine+Nitrates)
• Clyde Yancy

• Drug Therapy for Chronic HF II: Focus on newer therapies (Sacubitril/Valsartan, Ivabradine, SGLT2 inhibitors)
• Mark Drazner

• HFpEF: Epidemiology, Risk Factors, Diagnosis, Management (for the boards)
• Sanjiv Shah

• Pulmonary Hypertension
• Jonathan Rich

• Management of Common Arrhythmias I – Atrial Fib and Flutter
• Roderick Tung

• Management of Common Arrhythmias in HF II
• Roderick Tung

• Device Therapy in Heart Failure I – Sudden Death Prevention
• Wendy Tzou

• Device Therapy in Heart Failure II – CRT
• Wendy Tzou

• Management of the Hospitalized HF Patient
• Maria Rosa Costanzo

• Cardio Renal Failure Interactions in Heart Failure
• Jeff Testani

• Specific Heart Failure Syndromes

• Specific Etiologies of HF I: Common Etiologies (CAD, ETOH, Peripartum, Myocarditis)
• Akshay Desai

• Specific Etiologies of HF II: Inherited HF syndromes (including HCM, ARVC, and LVNC)
• Jane Wilcox

• Specific Etiologies of HF III: Infiltrative Disorders and Restrictive Cardiomyopathy (Amyloidosis, Sarcoidosis, Hemochromatosis, Fabry)
• Sanjiv Shah

• Q&A Panel II
• Akshay Desai, Nancy Sweitzer, Jonathan Rich, Maria Rosa
• Guest: James Fang

• Shock/MCS

• Cardiogenic Shock Management
• Nancy Sweitzer

• MCS I: Durable MCS Devices and Outcomes
• Joseph Rogers

• MCS II: Temporary Support Devices and ECMO for the Boards
• Jennifer Cowger

• MCS III: MCS Complications and Patient Management
• Jennifer Cowger

• MCS IV: Interactive Shock and Device Management
• Daniel Burkhoff, Jennifer Cowger, Joseph Rogers, Nancy Sweitzer

• Special Topics in HF

• Assessment of Functional Capacity including cardiopulmonary exercise testing
• Gregory Lewis

• Adult Congenital Heart Disease for the HF Specialist
• Eric Krieger

• Issues in Chronic HF Disease Management (Biomarkers, Remote Monitoring, Lifestyle Interventions)
• Akshay Desai

• Management of Valvular Heart Disease in Heart Failure (including functional MR, low gradient AS, tricuspid regurgitation)
• Jane Wilcox

• Management of Comorbidities in Heart Failure – Diabetes, Sleep Disorders, Iron Deficiency/Anemia, COPD
• Maria Rosa Costanzo

Q&A Panel III

Akshay Desai, Nancy Sweitzer, Jonathan Rich